26 November 2020
The Russian Direct Investment Fund (RDIF) is looking at possible production of the Russian Sputnik V anti-coronavirus vaccine in Germany, RDIF’s CEO Kirill Dmitriev said.
He noted that Hungary is one of the first European countries to demonstrate interest to the Russian vaccine.
“This week we expect a big delegation from France to visit Moscow. We are working with a big number of European countries. We will probably manufacture our vaccine in Germany,” he said in an interview with the Rossiya-24 television channel.
According to Dmitriev, Russia will continue cooperation with Europe on issues with the vaccine production, despite the problems stemming from political gaps. “The European Union will obviously be a difficult market, regrettably, due to political reasons,” he said. “But we will continue to work with the European Union. On October 22, we filed a request for approval with the European Medical Association.”
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024